Withdrawn ID: | w230 |
---|---|
Canonical SMILES: | |
Standard InChI: | |
Standard InChIKey: | |
ATC class(es): | N05CD03 |
Molecular Formula: | C16H12FN3O3 |
Molweight: | 313.283 |
Withdrawn due to drug safety reasons: | Yes |
---|---|
First approved: | 1975 |
First withdrawn: | 1996 |
Last withdrawn: | 1996 |
Reference: | https://dij.sagepub.com/content/35/1/293.full.pdf |
Total reported cases (submitted by medical professionals) with Flunitrazepam as primary suspect: | 9 |
---|
Hospitalization (initial or prolonged): | 5 |
---|---|
Life-Threatening condition: | 1 |
Side-effect | Case number |
---|---|
Overdose | 4 |
Altered state of consciousness | 2 |
Drug withdrawal syndrome | 2 |
Toxicity to various agents | 2 |
Hallucination, visual | 2 |
Delirium | 2 |
Coma | 2 |
Dehydration | 1 |
COORDINATION ABNORMAL | 1 |
Delusion | 1 |
Disorientation | 1 |
DIZZINESS | 1 |
DRUG ABUSER | 1 |
Drug dependence | 1 |
Drug eruption | 1 |
DRUG INTERACTION | 1 |
DRUG LEVEL INCREASED | 1 |
ASTHENIA | 1 |
Hallucination, auditory | 1 |
GENERAL PHYSICAL HEALTH DETERIORATION | 1 |
Generalised tonic-clonic seizure | 1 |
Heart rate abnormal | 1 |
Hepatic function abnormal | 1 |
Hyporeflexia | 1 |
Hypotension | 1 |
Inflammation | 1 |
Intentional overdose | 1 |
LOSS OF CONSCIOUSNESS | 1 |
Neuroleptic malignant syndrome | 1 |
NYSTAGMUS | 1 |
Oxygen saturation decreased | 1 |
Pneumonia aspiration | 1 |
Respiratory disorder | 1 |
Rhabdomyolysis | 1 |
Suicide attempt | 1 |
Target UniProtKB ID | Activity in nm | Target Name | Target gene |
---|---|---|---|
P18507 | 1.4 | Gamma-aminobutyric acid receptor subunit gamma-2 | GBRG2_HUMAN |
Toxicity class: | 6 |
---|---|
Toxicity type: | multiple |
LD50: | 8687 mg/kg |
ChEBML: | CHEMBL13280 |
---|---|
DrugBank: | DB01544 |